| 'Conditioning'the heart DJ Hausenloy, DM Yellon Practical Cardiovascular Risk Management 5 (2), 6-8, 2007 | | 2007 |
| ‘Conditioning’the heart during surgery V Venugopal, A Ludman, DM Yellon, DJ Hausenloy European journal of cardio-thoracic surgery 35 (6), 977-987, 2009 | 78 | 2009 |
| " FINAL ACCEPTED VERSION DJ Hausenloy, MM Mocanu, DM Yellon | | 2004 |
| “Conditional Conditioning” in cardiac bypass surgery DJ Hausenloy, DM Yellon Basic research in cardiology 107, 1-6, 2012 | 21 | 2012 |
| “Zinc and cardioprotection: the missing link” MM Mocanu, DM Yellon American Journal of Physiology-Heart and Circulatory Physiology 296 (1 …, 2009 | 11 | 2009 |
| 013 Modulating mitochondrial dynamics as a novel cardioprotective strategy SB Ong, S Arjun, SY Lim, SM Davidson, DM Yellon, DJ Hausenloy Heart 96 (Suppl 1), A10-A11, 2010 | | 2010 |
| 014 Atorvastatin protects human myocardium from lethal ischaemia-reperfusion injury by activating the risk pathway PSC Rees, GG Babu, EA Boston-Griffiths, G Bognolo, M Hayward, ... Heart 96 (Suppl 1), A11-A11, 2010 | 1 | 2010 |
| 015 Mitochondrial cyclophilin-D as a therapeutic target for post-myocardial infarction heart failure SY Lim, S Arjun, AN Price, SM Davidson, MF Lythgoe, DJ Hausenloy, ... Heart 96 (Suppl 1), A11-A11, 2010 | | 2010 |
| 018 The interaction between the humoural and neural pathways underlying remote ischaemic preconditioning SY Lim, DM Yellon, DJ Hausenloy Heart 96 (Suppl 1), A13-A13, 2010 | | 2010 |
| 038 Detrimental effects of erythropoietin as an adjunct to PPCI: a randomised controlled trial in acute MI using cardiac MRI AJ Ludman, J Hasleton, G Babu, E Boston-Griffiths, V Venugopal, ... Heart 96 (Suppl 1), A22-A23, 2010 | | 2010 |
| 100 Role of PI3kinase and p70S6kinase activation in delayed preconditioning A Kis, DM Yellon, GF Baxter European Journal of Heart Failure Supplements 2, 12-12, 2003 | | 2003 |
| 107 Remote ischaemic preconditioning and human atrial trabeculae in the diabetic heart R Sirohi, L Candilio, G Babu, N Roberts, D Lawrence, A Sheik, S Kolvekar, ... Heart 98 (Suppl 1), A61-A61, 2012 | 1 | 2012 |
| 116 Matrix metalloproteinase inhibition attenuates reperfusion injury, independently of and additive to mitochondrial permeability transition pore inhibition RM Bell, C Hendy, D Bruce-Hickman, S Davidson, R Breckenridge, ... Heart 98 (Suppl 1), A65-A66, 2012 | | 2012 |
| 123 THE EFFECTS OF MULTI-LIMB REMOTE ISCHAEMIC PRECONDITIONING IN PATIENTS UNDERGOING CARDIAC BYPASS SURGERY L Candilio, A Malik, C Ariti, M Barnard, S Wright, A Smith, S Giannaris, ... Heart 99 (suppl 2), A74, 2013 | 3 | 2013 |
| 124 MULTI-LIMB REMOTE ISCHAEMIC PRECONDITIONING REDUCES MYOCARDIAL INJURY IN DIABETIC PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY LC Candilio, B Babu, AM Malik, CA Ariti, DL Lawrence, CDS Di Salvo, ... Heart 99 (suppl 2), A74, 2013 | | 2013 |
| 15: Preconditioning: what is its potential? RM Bell, DM Yellon Challenges in Acute Coronary Syndromes, 234, 2001 | | 2001 |
| 16 Matrix metalloproteinase inhibition is a parallel pathway to protection against reperfusion injury, both independent and additive to mitochondrial permeability transition … RM Bell, C Hendry, D Bruce-Hickman, S Davidson, R Breckenridge, ... Heart 97 (24), e8-e8, 2011 | | 2011 |
| 162 Polymersomes functionalized with HSP70–novel, synthetic cardioprotective nanovesicles D Radenkovic, S Arjun, A Poma, S Nyberg, B Battaglia, DM Yellon, ... Heart 102 (Suppl 6), A115-A115, 2016 | 9 | 2016 |
| 19 例选择性冠状动脉造影正常胸痛患者的临床分析 欧宁， 施海明 临床荟萃 14 (14), 638-639, 1999 | | 1999 |
| 193 The role of the pi3k-alpha isoform in cardioprotection X Rossello, D He, JA Riquelme, S Davidson, DM Yellon Heart 103 (Suppl 5), A131-A131, 2017 | | 2017 |
